Citigroup Inc Direxion Daily S&P Biotech Bea Transaction History
Citigroup Inc
- $163 Billion
- Q4 2024
A detailed history of Citigroup Inc transactions in Direxion Daily S&P Biotech Bea stock. As of the latest transaction made, Citigroup Inc holds 400 shares of LABD stock, worth $3,376. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400
Previous 400
-0.0%
Holding current value
$3,376
Previous $2,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding LABD
# of Institutions
28Shares Held
2.45MCall Options Held
1.07MPut Options Held
144K-
Virtu Financial LLC New York, NY1.3MShares$11 Million0.5% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA511KShares$4.31 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY225KShares$1.9 Million2.28% of portfolio
-
Jane Street Group, LLC New York, NY152KShares$1.28 Million0.0% of portfolio
-
Two Sigma Securities, LLC New York, NY61.2KShares$516,4680.06% of portfolio